..
Soumettre le manuscrit arrow_forward arrow_forward ..

Combination Therapy for Chronic Lymphoid Leukemia

Abstract

Satadal Barik

For decades, the treatment of chronic lymphocytic leukemia (CLL) has relied on cytotoxic drugs with incremental benefit from anti-CD20 monoclonal antibodies. However, in the past 5 years, targeted drugs have fundamentally changed the management and outcome of CLL

Partagez cet article

Indexé dans

arrow_upward arrow_upward